Literature DB >> 3426170

Seizures during barbiturate withdrawal: relation to blood level.

W H Theodore1, R J Porter, R F Raubertas.   

Abstract

We studied 21 patients with complex partial seizures during phenobarbital (PB) or primidone withdrawal. Blood levels were measured daily, and seizure frequency was monitored by nursing staff and EEG-video telemetry. Patients were monitored for one week of baseline and for five weeks after PB tapering was initiated (withdrawal). Most were observed for at least one week after levels were undetectable. When ranked seizure counts were averaged, there was a tendency for seizure rates to be highest as PB levels passed through the range 15 to 20 mg/l, compared with rates at higher or lower PB levels. There was little or no relation between the rate of PB withdrawal, other drug therapy, or initial PB level and the ratio of highest seizure frequency to mean seizure frequency. Patients withdrawing from PB may be most likely to experience an increase in seizure frequency when their PB blood level falls below 20 mg/l.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426170     DOI: 10.1002/ana.410220515

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

Review 1.  Currently available antiepileptic drugs.

Authors:  Steven C Schachter
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

2.  Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism.

Authors:  Jean M Bidlack; Harold H Morris
Journal:  Seizure       Date:  2008-08-03       Impact factor: 3.184

Review 3.  Evaluation of antiepileptic drug efficacy. A review of clinical trial design.

Authors:  G W Pledger; D Schmidt
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 4.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.